Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu

A Study to Evaluate Glucose and Insulin Response to Nutralin

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01275820
Recruitment Status : Completed
First Posted : January 12, 2011
Last Update Posted : January 12, 2011
Vintek, LLC
Information provided by:
Avera McKennan Hospital & University Health Center

Brief Summary:
The purpose of this study is to evaluate how an investigational food product affects a healthy person's blood sugar and insulin levels.

Condition or disease Intervention/treatment
Diabetes Dietary Supplement: Nutralin

Detailed Description:
The investigational food product has helped decrease the amount of insulin needed in treating diabetic dogs and has improved the dogs' longevity and quality of life. Observational analysis by trained veterinarians has indicated that the natural fluctuations in blood glucose levels do not exist in dogs using the product. The hypothesis for this study is that healthy human subjects will have an increase in insulin levels after consuming the investigational food product.

Layout table for study information
Study Type : Observational
Actual Enrollment : 10 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: A Study to Evaluate Glucose and Insulin Response to Nutralin
Study Start Date : June 2010
Actual Primary Completion Date : August 2010
Actual Study Completion Date : September 2010

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Blood Sugar

Group/Cohort Intervention/treatment
All 10 subjects in the study will consume the investigational food product.
Dietary Supplement: Nutralin
Food product to be taken 15 minutes prior to each of the three main meals of the day.
Other Name: No other names at this time.

Primary Outcome Measures :
  1. Glucose blood level [ Time Frame: 4 weeks ]
    Measure the change in blood sugar levels

Secondary Outcome Measures :
  1. Dosage of Insulin [ Time Frame: 4 weeks ]
    Measure the levels of insulin

Biospecimen Retention:   Samples Without DNA

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Individuals in and around the area of Sioux Falls, SD

Inclusion Criteria:

  • Men and women who are at least 18 years of age
  • Non-diabetic

Exclusion Criteria:

  • Diabetes
  • Women who are pregnant, breastfeeding or planning to become pregnant
  • Current and active liver or kidney disease
  • Any food allergies
  • Celiac disease

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01275820

Layout table for location information
United States, South Dakota
Avera Research Institute
Sioux Falls, South Dakota, United States, 57105
Sponsors and Collaborators
Avera McKennan Hospital & University Health Center
Vintek, LLC
Layout table for investigator information
Principal Investigator: Edward Zawada, MD Avera McKennan Hospital & University Health Center

Additional Information:
Layout table for additonal information
Responsible Party: Dave Kuper, RPh, Avera Research Institute Identifier: NCT01275820    
Other Study ID Numbers: ARI-1330-Nutralin
First Posted: January 12, 2011    Key Record Dates
Last Update Posted: January 12, 2011
Last Verified: January 2011
Keywords provided by Avera McKennan Hospital & University Health Center:
diabetes, insulin, blood sugar
Additional relevant MeSH terms:
Layout table for MeSH terms
Hypoglycemic Agents
Physiological Effects of Drugs